Targeting type III secretion in Yersinia pestis

Antimicrobial Agents and Chemotherapy

Volumn 53, Issue 2, 2009, Pages 385-392

  Pan, Ning J ^a   Brady, Michael J ^a   Leong, John M ^a   Goguen, Jon D ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,3 BIS[3 (4,5 DIHYDRO 1H IMIDAZOL 2 YL)PHENYL]UREA; 4,4' THIOBIS(3 METHYLPHENOL); 5 CYANO 6 (4 METHYLBENZYLTHIO)PICOLINIC ACID; 5 OXO 5 [5 (1 PHENYL 3 4 TOLYL 1H PYRZOL 4 YL) 3 (THIOPHEN 2 YL) 4,5 DIHYDRO 1H PYRAZOL 1 YL]PENTANOIC ACID; ANTIINFECTIVE AGENT; CARBANILAMIDE DERIVATIVE; HYBRID PROTEIN; PICOLINIC ACID DERIVATIVE; UNCLASSIFIED DRUG; VALERIC ACID DERIVATIVE; YERSINIA OUTER PROTEIN E;

ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; CONTROLLED STUDY; CYTOTOXICITY; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN CELL; MOLECULAR LIBRARY; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; PROTEIN TARGETING; STRUCTURE ACTIVITY RELATION; TYPE III SECRETION SYSTEM; YERSINIA PESTIS;

ANTI-BACTERIAL AGENTS; ANTIBODIES, BACTERIAL; BACTERIAL OUTER MEMBRANE PROTEINS; BACTERIAL TRANSLOCATION; DRUG EVALUATION, PRECLINICAL; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; HELA CELLS; HUMANS; PLASMIDS; YERSINIA PESTIS;

EID: 59749087910     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00670-08     Document Type: Article

References (43)

1. Abe, A. 2002. Development of the screening system for the bacterial type III secretion apparatus inhibitor. Jpn. J. Antibiot. 55:331-336.
2. Bailey, L., A. Gylfe, C. Sundin, S. Muschiol, M. Elofsson, P. Nordstrom, B. Henriques-Normark, R. Lugert, A. Waldenstrom, H. Wolf-Watz, and S. Bergstrom. 2007. Small molecule inhibitors of type III secretion in Yersinia block the Chlamydia pneumoniae infection cycle. FEBS Lett. 581:587-595.
3. Ben-Gurion, R., and A. Shafferman. 1981. Essential virulence determinants of different Yersinia species are carried on a common plasmid. Plasmid 5:183-187.
4. Blaylock, B., K. E. Riordan, D. M. Missiakas, and O. Schneewind. 2006. Characterization of the Yersinia enterocolitica type III secretion ATPase YscN and its regulator, YscL. J. Bacteriol. 188:3525-3534.
5. Boland, A., M. P. Sory, M. Iriarte, C. Kerbourch, P. Wattiau, and G. R. Cornelis. 1996. Status of YopM and YopN in the Yersinia Yop virulon: YopM of Y. enterocolitica is internalized inside the cytosol of PU5-1.8 macrophages by the YopB, D, N delivery apparatus. EMBO J. 15:5191-5201.
6. Brubaker, R. R. 1967. Growth of Pasteurella pseudotuberculosis in simulated intracellular and extracellular environments. J. Infect. Dis. 117:403-417.
7. +, the low calcium-response, and acute disease. Adv. Exp. Med. Biol. 603:116-129.
8. Campellone, K. G., A. Giese, D. J. Tipper, and J. M. Leong. 2002. A tyrosine-phosphorylated 12-amino-acid sequence of enteropathogenic Escherichia coli Tir binds the host adaptor protein Nck and is required for Nck localization to actin pedestals. Mol. Microbiol. 43:1227-1241.
9. Christie, A. B. 1982. Plague: review of ecology. Ecol. Dis. 1:111-115.
10. Cornelis, G. R. 2000. Molecular and cell biology aspects of plague. Proc. Natl. Acad. Sci. USA 97:8778-8783.
11. Cornelis, G. R. 2002. The Yersinia Ysc-Yop 'type III' weaponry. Nat. Rev. Mol. Cell Biol. 3:742-752.
12. Cornelis, G. R., and F. Van Gijsegem. 2000. Assembly and function of type III secretory systems. Annu. Rev. Microbiol. 54:735-774.
13. Dahlgren, M. K., A. M. Kauppi, I. M. Olsson, A. Linusson, and M. Elofsson. 2007. Design, synthesis, and multivariate quantitative structure-activity relationship of salicylanilides - potent inhibitors of type III secretion in Yersinia. J. Med. Chem. 50:6177-6188.
14. Dehio, C., and M. Meyer. 1997. Maintenance of broad-host-range incompatibility group P and group Q plasmids and transposition of Tn5 in Bartonella henselae following conjugal plasmid transfer from Escherichia coli. J. Bacteriol. 179:538-540.
15. Deng, W., Y. Li, P. R. Hardwidge, E. A. Frey, R. A. Pfuetzner, S. Lee, S. Gruenheid, N. C. Strynakda, J. L. Puente, and B. B. Finlay. 2005. Regulation of type III secretion hierarchy of translocators and effectors in attaching and effacing bacterial pathogens. Infect. Immun. 73:2135-2146.
16. Edqvist, P. J., M. Aili, J. Liu, and M. S. Francis. 2007. Minimal YopB and YopD translocator secretion by Yersinia is sufficient for Yop-effector delivery into target cells. Microbes Infect. 9:224-233.
17. Ferber, D. M., and R. R. Brubaker. 1981. Plasmids in Yersinia pestis. Infect. Immun. 31:839-841.
18. Galan, J. E., and H. Wolf-Watz. 2006. Protein delivery into eukaryotic cells by type III secretion machines. Nature 444:567-573.
19. Gauthier, A., M. L. Robertson, M. Lowden, J. A. Ibarra, J. L. Puente, and B. B. Finlay. 2005. Transcriptional inhibitor of virulence factors in enteropathogenic Escherichia coli. Antimicrob. Agents Chemother. 49:4101-4109.
20. Hudson, D. L., A. N. Layton, T. R. Field, A. J. Bowen, H. Wolf-Watz, M. Elofsson, M. P. Stevens, and E. E. Galyov. 2007. Inhibition of type III secretion in Salmonella enterica serovar Typhimurium by small-molecule inhibitors. Antimicrob. Agents Chemother. 51:2631-2635.
21. Kauppi, A. M., C. D. Andersson, H. A. Norberg, C. Sundin, A. Linusson, and M. Elofsson. 2007. Inhibitors of type III secretion in Yersinia: design, synthesis and multivariate QSAR of 2-arylsulfonylamino-benzanilides. Bioorg. Med. Chem. 15:6994-7011.
22. Kauppi, A. M., R. Nordfelth, H. Uvell, H. Wolf-Watz, and M. Elofsson. 2003. Targeting bacterial virulence: inhibitors of type III secretion in Yersinia. Chem. Biol. 10:241-249.
23. Linington, R. G., M. Robertson, A. Gauthier, B. B. Finlay, R. van Soest, and R. J. Andersen. 2002. Caminoside A, an antimicrobial glycolipid isolated from the marine sponge Caminus sphaeroconia. Org. Lett. 4:4089-4092.
24. Marketon, M. M., R. W. DePaolo, K. L. DeBord, B. Jabri, and O. Schneewind. 2005. Plague bacteria target immune cells during infection. Science 309:1739-1741.
25. Michiels, T., P. Wattiau, R. Brasseur, J. M. Ruysschaert, and G. Cornelis. 1990. Secretion of Yop proteins by yersiniae. Infect. Immun. 58:2840-2849.
26. Mueller, C. A., P. Broz, S. A. Muller, P. Ringler, F. Erne-Brand, I. Sorg, M. Kuhn, A. Engel, and G. R. Cornelis. 2005. The V-antigen of Yersinia forms a distinct structure at the tip of injectisome needles. Science 310:674-676.
27. Murphy, K. C., and K. G. Campellone. 2003. Lambda Red-mediated recombinogenic engineering of enterohemorrhagic and enteropathogenic E. coli. BMC Mol. Biol. 4:11.
28. Muschiol, S., L. Bailey, A. Gylfe, C. Sundin, K. Hultenby, S. Bergstrom, M. Elofsson, H. Wolf-Watz, S. Normark, and B. Henriques-Normark. 2006. A small-molecule inhibitor of type III secretion inhibits different stages of the infectious cycle of Chlamydia trachomatis. Proc. Natl. Acad. Sci. USA 103:14566-14571.
29. Negrea, A., E. Bjur, S. E. Ygberg, M. Elofsson, H. Wolf-Watz, and M. Rhen. 2007. Salicylidene acylhydrazides that affect type III protein secretion in Salmonella enterica serovar Typhimurium. Antimicrob. Agents Chemother. 51:2867-2876.
30. Nordfelth, R., A. M. Kauppi, H. A. Norberg, H. Wolf-Watz, and M. Elofsson. 2005. Small-molecule inhibitors specifically targeting type III secretion. Infect. Immun. 73:3104-3114.
31. Pan, N., C. Lee, and J. Goguen. 2007. High throughput screening for small-molecule inhibitors of type III secretion in Yersinia pestis. Adv. Exp. Med. Biol. 603:367-375.
32. Pettersson, J., R. Nordfelth, E. Dubinina, T. Bergman, M. Gustafsson, K. E. Magnusson, and H. Wolf-Watz. 1996. Modulation of virulence factor expression by pathogen target cell contact. Science 273:1231-1233.
33. Rosqvist, R., K. E. Magnusson, and H. Wolf-Watz. 1994. Target cell contact triggers expression and polarized transfer of Yersinia YopE cytotoxin into mammalian cells. EMBO J. 13:964-972.
34. Rosqvist, R., C. Persson, S. Hakansson, R. Nordfeldt, and H. Wolf-Watz. 1995. Translocation of the Yersinia YopE and YopH virulence proteins into target cells is mediated by YopB and YopD. Contrib. Microbiol. Immunol. 13:230-234.
35. Rubin, E. J., B. J. Akerley, V. N. Novik, D. J. Lampe, R. N. Husson, and J. J. Mekalanos. 1999. In vivo transposition of mariner-based elements in enteric bacteria and mycobacteria. Proc. Natl. Acad. Sci. USA 96:1645-1650.
36. Shao, F. 2008. Biochemical functions of Yersinia type III effectors. Curr. Opin. Microbiol. 11:21-29
37. Sory, M. P., and G. R. Cornelis. 1994. Translocation of a hybrid YopE-adenylate cyclase from Yersinia enterocolitica into HeLa cells. Mol. Microbiol. 14:583-594.
38. Trosky, J. E., A. D. Liverman, and K. Orth. 2008. Yersinia outer proteins: Yops. Cell. Microbiol. 10:557-565.
39. Viboud, G. I., and J. B. Bliska. 2005. Yersinia outer proteins: role in modulation of host cell signaling responses and pathogenesis. Annu. Rev. Microbiol. 59:69-89.
40. Wattiau, P., B. Bernier, P. Deslee, T. Michiels, and G. R. Cornelis. 1994. Individual chaperones required for Yop secretion by Yersinia. Proc. Natl. Acad. Sci. USA 91:10493-10497.
41. Welkos, S., M. L. Pitt, M. Martinez, A. Friedlander, P. Vogel, and R. Tammariello. 2002. Determination of the virulence of the pigmentation-deficient and pigmentation-/plasminogen activator-deficient strains of Yersinia pestis in non-human primate and mouse models of pneumonic plague. Vaccine 20:2206-2214.
42. Yother, J., T. W. Chamness, and J. D. Goguen. 1986. Temperature-controlled plasmid regulon associated with low calcium response in Yersinia pestis. J. Bacteriol. 165:443-447.
43. Zhang, J. H., T. D. Chung, and K. R. Oldenburg. 1999. A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J. Biomol. Screen. 4:67-73.